Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Understanding how increased eye pressure affects glaucoma damage

Official title: Effects of Elevated Intraocular Pressure on the Lamina Cribrosa

Run by NYU Langone Health · NCT03400137 · Data updated 2026-11-12

This study tests how a short increase in eye pressure affects the optic nerve in people with glaucoma to better understand the damage it causes.

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment150 (estimated)
SponsorNYU Langone Health
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedMarch 7, 2018
Main results expectedMay 8, 2024
Study endsMay 8, 2024
Registry record updatedAugust 31, 2023
Trial IDNCT03400137 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include healthy volunteers, glaucoma suspects, and patients with diagnosed glaucoma who meet specific inclusion criteria.

Probably not a fit

Patients with media opacity, strabismus, or diabetes with retinopathy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance the understanding of the mechanisms behind glaucomatous damage by examining the effects of elevated intraocular pressure (IOP) on the optic nerve head and lamina cribrosa in living subjects. Participants will undergo a brief increase in eye pressure, and the resulting changes will be assessed using optical coherence tomography imaging. The study will measure the deformation of the lamina cribrosa in response to IOP modulation, providing insights into the pathophysiology of glaucoma.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of glaucoma, potentially reducing vision loss for patients.

How similar studies have gone: While studies on IOP modulation exist, this specific approach focusing on in-vivo mechanical responses is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Healthy volunteers

* No family history (first degree relative) of glaucoma.
* No history of IOP \>22 mmHg.
* Normal appearing optic discs and RNFL on dilated fundus examination.
* Normal Swedish interactive thresholding algorithm (SITA) standard perimetry tests as defined by glaucoma hemifield test (GHT) within normal limits.

Glaucoma suspects

* Normal visual field as defined above.
* Either IOP between 25 to 30 mmHg with central corneal thickness \< 550µm, or a difference ≥ 0.2 in cup to disc ratio between eyes.

Glaucoma

* Glaucomatous ONH abnormality: rim thinning, notching, undermining (excavation) or diffuse or localized RNFL defects that are characteristic of glaucoma.
* Two consecutive abnormal SITA standard perimetry tests with GHT outside normal limits.

Exclusion Criteria:

* Media opacity (e.g. lens, vitreous, cornea).
* Strabismus, nystagmus or a condition that would prevent fixation.
* Diabetes with evidence of retinopathy.
* Previous intraocular surgery or ocular trauma (with the exception of laser procedures and subjects that have undergone uneventful cataract surgery more than 6 months from enrollment date).
* Neurological and non-glaucomatous causes for visual field damage.
* Any intraocular non-glaucomatous ocular disorders.

Where it's running

  • NYU Langone Health
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.